Capital One headquarters in McLean, Virginia on February 20, 2024.
Brendan Smialowski | AFP | Getty Images
The Consumer Financial Protection Bureau announced Tuesday that it was suing Capital One for misleading consumers about their savings account interest rates and “cheating” them out of more than $2 billion in interest.
The agency said in a statement Capital One deceived holders of its “360 Savings” account by conflating it with its newer and higher-yield savings account option, the “360 Performance Savings” account. The bank allegedly failed to notify 360 Savings account holders of the newer option and marketed the two products similarly to lead customers to believe they were the same.
However, the interest rates of the two options were substantially different, according to the CFPB. Capital One increased the 360 Performance Savings interest rate from 0.4% in April 2022 to 4.35% in January 2024, while it lowered and then froze the 360 Savings rate at 0.3% between late 2019 to mid-2024, the agency said.
Despite its relatively low interest rate, the CFPB alleged, the 360 Savings account was advertised as a high-interest savings account. The bureau said Capital One aimed to keep 360 Savings users in the dark about the higher-yield option by replacing all references to the account with the similarly named 360 Performance Savings option on its website, excluding account holders from marketing campaigns advertising the higher-yield account and forbidding employees from notifying account holders about the 360 Performance Savings option.
“The CFPB is suing Capital One for cheating families out of billions of dollars on their savings accounts,” said CFPB Director Rohit Chopra in a news release. “Banks should not be baiting people with promises they can’t live up to.”
In a statement, Capital One denied the allegations and said it transparently marketed its 360 Performance Savings account.
“We are deeply disappointed to see the CFPB continue its recent pattern of filing eleventh hour lawsuits ahead of a change in administration. We strongly disagree with their claims and will vigorously defend ourselves in court,” the company said in a statement.
The bank added the 360 Performance Savings product was “marketed widely, including on national television, with the simplest and most transparent terms in the industry.”
With the Federal Reserve just hours away from its latest decision on interest rates, President Donald Trump on Wednesday lambasted Chair Jerome Powell, calling him “stupid” while doubting the central bank would cut.
In his latest in a series of attacks on Powell that go back years, Trump said the Fed’s key borrowing rate should be at least two percentage points lower.
“So we have a stupid person. Frankly, you probably won’t cut today,” Trump said in impromptu remarks just outside the White House. “Europe had 10 cuts, and we had none. And I guess he’s a political guy, I don’t know. He’s a political guy who’s not a smart person, but he’s costing the country a fortune.”
The remarks came just about four hours before the rate-setting Federal Open Market Committee was to release its statement on interest rates, along with an update of where it sees policy and several key economic measures heading over the next several years.
Market pricing indicates no probability of cut at this meeting, with the next move expected in September. The Fed currently targets its overnight borrowing rate in a range between 4.25%-4.50%.
Powell and his colleagues have expressed hesitation about adjusting rates with so many unanswered questions regarding the economy.
For one, the longer-term impact of Trump’s tariffs is not known. Inflation indicators are little changed since the tariffs were implemented in April, but various factors have colluded to keep blunt the impact.
Trump, though, said higher interest rates rates are costing the U.S. “hundreds of billions” of dollars in financing costs that could be saved if the Fed would ease.
“If he’s worried about inflation, that’s OK. I understand that. I don’t think there’s going to be any. So far there hasn’t,” Trump said.
“But now we have a man that just refuses to lower the Fed rate, just refuses to do and he’s not a smart person,” the president added. “I don’t even think he’s that political. I think he hates me, but that’s OK.”
Trump and Powell recently met at the White House, though little has been disclosed about what was discussed. Powell and his colleagues have vowed they will not be swayed by political pressure, which has ramped up to include other administration officials, including Vice President JD Vance.
Trump even mused about appointing himself as Fed chair, saying, “I’d do a much better job than these people.”
Powell’s term expires in May 2026, and Trump has said he intends to name a successor soon.
Check out the companies making headlines in premarket trading. Sunrun — Shares fell nearly 2% following a downgrade to sector perform from outperform by RBC Capital Markets. The stock on Tuesday recorded its biggest one-day loss in its history amid a sell-off in solar names. CERo Therapeutics Holdings — Stock in the immunotherapy company pulled back about 28%. On Tuesday, the U.S. Food and Drug Administration gave the company’s acute myeloid leukemia drug CER-1236 an orphan drug designation . Shares rose more than 188% on that news. Chemours — The chemical stock dropped about 1% after an updated second-quarter forecast showed weakness in a key profit metric. Chemours said it expects consolidated adjusted EBITDA — or earnings before interest, taxes, depreciation and amortization — of $215 million to $225 million for the period. Wall Street expectations called for $236 million, according to FactSet. Regencell Bioscience — Shares dropped 13% after an eyewatering move higher this week . The Hong Kong-based developer of traditional Chinese herbal treatments has said it can treat childhood ADHD and autism. Regencell jumped 30% on Tuesday, and soared 283% Monday, following a 38-for-1 stock split. It’s gained more than 59,000% this year. Oracle — The software company gained more than 1% after Guggenheim raised its price target on the stock to the highest on the Street. Analyst John DiFucci said Oracle is “on the precipice of a narrative shift that has been decades of technology innovation in the making.” Zoetis — Shares of the animal health company slipped 1% following a downgrade at Stifel to hold from buy. The firm said it expects Zoetis’ revenue growth to decelerate further amid increasing competition. Korn Ferry — Shares of the consulting firm gained about 10% after fourth-quarter results surpassed analyst estimates on the top and bottom line. Korn Ferry earned $1.32 per share, excluding items, on revenue of $712 million. Analysts polled by FactSet expected a profit of $1.26 per share and revenue of $689.9 million. Circle Internet Group — Stock in the company behind stablecoin USDC advanced 3%, after the U.S. Senate passed the GENIUS bill . The legislation is the first of its kind and establishes federal guidelines for digital dollars that are pegged to the greenback. — CNBC’s Sarah Min, Michelle Fox, Alex Harring, Fred Imbert and Jesse Pound contributed reporting.
Wedbush Securities’ Dan Ives, who launched an artificial intelligence exchange-traded fund this month, sees software as the subcategory to watch within the space.
According to Ives, it’s experiencing a “golden age.”
“Software is going to be driving … a lot of the use cases,” the firm’s global head of technology research told CNBC’s “ETF Edge” this week. “But it’s trying to understand: Who within software? Just because they say ‘AI’ on a conference call doesn’t make them an AI player.”
Ives runs the Dan Ives Wedbush AI Revolution ETF, which trades under the ticker IVES. Ives’ goal is to focus on stocks that are transforming the AI landscape.
“I believe the market is still massively underestimating what the growth is going to look like for the AI revolution in tech,” he said. “For us, it’s not just Mag Seven. It’s not just those first four or five names… It’s trying to identify names that maybe today thematically you don’t even consider an AI name.”
He forecasts Oracle will be “the epicenter of the AI theme over the next six, nine, 12 months in terms of software.” As of Tuesday’s market close, Oracle shares are up almost 62% over the past two months. It’s IVES’ fourth-largest holding, according to the firm’s website.
IVES’ other software holdings include Palantir, IBM and Salesforce. They’re also winners over the past two months — with Palantir shares soaring more than 47%.
Altogether, IVES’ holdings cover 30 companies that span multiple industries. They include hyperscalers, cybersecurity, consumer platforms and robotics. According to Ives, the list was compiled from his deep dives into major AI players.
“Around the world investors always say, ‘How do you play AI? How do you play the theme?'” Ives said. “All of our research can put it in a way investors could play this regardless of where they are and who they are.”
IVES is up almost 3% since its June 4 launch. In an email to CNBC, Ives wrote that the ETF has $183 million in assets under management as of Tuesday’s market close.
Ives plans to reevaluate the AI 30 every quarter.
“There could be a name today that’s not on there,” he said. “Six months from now, if we find that’s a name that’s become more and more of an AI play, then we’ll put them on there.”
Ives contends the tech trade is still worth the investment – even for investors who have missed out on the run over the past few years.
“If you focus just on valuation, you miss every transformational tech stock of the last 20 years,” Ives said.
Sign up for our weekly newsletter that goes beyond the livestream, offering a closer look at the trends and figures shaping the ETF market.